Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Maxime Dely: CAR T Cell Therapy Starts With Collection
Oct 2, 2026, 14:40

Maxime Dely: CAR T Cell Therapy Starts With Collection

Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:

“Before CAR T, there is the collection.

CAR T cell therapy begins well before the genetic modification of T cells: it starts with eukapheresis, which collects the patient’s mononuclear cells, including the T lymphocytes that will be used to manufacture the cellular product.

This first step is critical: cell composition, viability and collection quality can influence the subsequent manufacturing process.

Apheresis technology is essential, but it is not enough. Successful collection also relies on the expertise, experience and vigilance of nurses, who adapt the procedure to each patient.

Before manufacturing CAR T cells, we first need to successfully collect them.”Maxime Dely: CAR T Cell Therapy Starts With Collection

Stay updated with Hemostasis Today.